Biogen Inc. buy Royal Bank of Canada
Start price
31.10.25
/
50%
€131.80
Target price
31.10.26
€181.48
Performance (%)
7.89%
Price
15:25
€142.20
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 7.89%. This prediction currently runs until 31.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biogen Inc. | 4.345% |
| iShares Core DAX® | 1.343% |
| iShares Nasdaq 100 | -1.235% |
| iShares Nikkei 225® | -2.386% |
| iShares S&P 500 | -0.486% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target lowered by analysts at Royal Bank Of Canada from $217.00 to $210.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat